VEXT SCIENCE PROFITABLE PRODUCER OF MEDICAL AND CONSUMER CANNABIS - - PowerPoint PPT Presentation

▶

Apr 27, 2023 131 likes •430 views

VEXT SCIENCE PROFITABLE PRODUCER OF MEDICAL AND CONSUMER CANNABIS OTCQX: VEXTF | CSE: VEXT www.vextscience.com DISCLAIMER FORWARD LOOKING STATEMENTS This presentation contains forward looking statement that relate to the Companys current

SLIDE 1

VEXT SCIENCE

PROFITABLE PRODUCER OF MEDICAL AND CONSUMER CANNABIS OTCQX: VEXTF | CSE: VEXT www.vextscience.com

SLIDE 2

2 | VEXT SCIENCE

This presentation contains forward looking statement that relate to the Company’s current expectations and views of future events and should be read together with more detailed information and fjnancial data and statements. The Presentation does not contain all the information you should con- sider before purchasing securities of the Company. In some cases, these forward- looking statement can be identifjed by words or phrases such as “may”, “might”, “will”, “expect”, ”anticipate”, ”estimate”, “intend”, “plan”, “indicate”, “seek”, “believe”, “predict” or “likely”. Or negative of these terms, or other similar expressions intended to identify forward-looking statements. The Company has based these forward-looking statements on its current expectations and projections about future events and fjnancial trends that it believes might affect its fjnancial condition, results of operations, business strategy and fjnancial needs. These forward-looking statements include, among other, things, statements relating to: the Company’s expectations regarding its revenue, expenses and operations; The Com- pany’s expectations regarding timing of the completion of the construction and related construction costs; the Company’s anticipated cash needs and its needs for additional fjnancing; the Com- pany’s intention and ability to grow the business and its operations: including its ability to complete business development and integrate multi-state operations: the Company’s expectations regarding harvesting of products and precut sales prices; expectations with respect to future production costs and capacity; expectations regarding our growth rates and growth plans and strategies; expectations with respect to the approval of the Company’s cannabis license holders; expectations with respect to the future growth of its medical and recreational cannabis services with license holders, and any commentary related to the legalization of adult-use, recreational cannabis and the timing related to such legalization, the Company’s expected business objectives for the next twelve months. For- ward-looking statements are based on certain assumptions and analyses made by the Company considering the experience and perception of historical trends, current conditions and expected future developments and other factors it believes are appropriate and are subject to risks and uncer-

tainties. In making the forward-looking statements included in this Presentation, the Company has

made various material assumption, including but not limited to (i) obtaining the necessary regulatory approvals; (ii) that regulatory requirements will be maintained; (iii) general business and economic conditions; (iv) the Company’s ability to successfully execute its plans and intentions; (v) the avail- ability of fjnancing on reasonable terms ; (vi) the Company’s ability to attract and retain skilled staff; (vii) market competition; (viii) the products and technology offered by the Company’s competitors; and (ix) that our current good relationships with our suppliers , service providers and other third parties will be maintained. Although we believe that the assumptions underlying these statements are reasonable, they may prove to be incorrect, and we cannot assure that the actual results will be consistent with these forward-looking statements. Given these risks, uncertainties and assumptions, prospective purchasers of the Company’s securities should not place undue reliance on these forward-looking statements. Whether actual results, performance or achievements will conform to the Company’s expectations and predictions is subject to several known and unknown risks, uncertainties, assumptions and other factors. The Company’s forward-looking statements are based on the reasonable beliefs, expectations and

pinions of management. Although the Company has attempted to identify important factors that

could cause actual results to differ materially form those contained in forward-looking statement, there may be other factors that cause results not to be as anticipated, estimated or intended. There is no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. We don not undertake to update or revise any forward-looking statements, except as, and to the extent required by, applicable securities laws in Canada. The common shares have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”) or any other securities laws. As a result, the common stock may not be offered or sold within the United States or to, or for the account or benefjt of, “U.S. persons” (as defjned in Regulations under the U.S. Securities Act), except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S> Securities Act and any other applicable securities laws.

FORWARD LOOKING STATEMENTS

DISCLAIMER

SLIDE 3

3 | VEXT SCIENCE

VEXT SCIENCE

Vext is executing a strategy to enter new markets rapidly with limited capital risk by leveraging operational expertise and brand strength

Monetizing manufacturing and distribution expertise with targeted partnerships in new markets Partnerships in 7 states with revenue streams anticipated to begin in 2020 Based in Phoenix, AZ with 130 employees Market leader in Arizona, third largest U.S. cannabis market Building a pipeline of future acquisitions with lower execution risk Listed CSE (May 2019) VEXT; OTCQX: VEXTF

SLIDE 4

4 | VEXT SCIENCE

COMPLEX MARKET

Makes Scalable Growth Challenging Vext’s footprint is expanding despite the market’s complexity.

Complicated U.S. market with local legalization measures makes traditional operational scale diffjcult National legislation to address a myriad of legal and financial hurdles stalled in Washington D.C.

SAFE Banking ACT – passed by House but stuck in Senate
STATES Act – reintroduced but no votes have taken place

Regulation creates market fragmentation and growth challenges

“Homestead Act” mentality – lots of players rushing into legal

states, many struggle to be profjtable and grow

Prohibited from scaling distribution across state lines
States targeting preferential granting of licenses (Illinois)
Likely US will decriminalize versus legalize

SLIDE 5

5 | VEXT SCIENCE

CONTRARIAN OPPORTUNITY

The Marijuana Index™ One-year price chart of 31 U.S. public cannabis companies

With a focus on profjtable growth Vext’s business models avoids the primary issues impacting many cannabis stocks

Source: North American Marijuana Index tracks the leading stocks operating in the legal cannabis industry in the United States and Canada. Companies must meet minimum trading requirements to be included on indices. To be included companies have a minimum market capitalization of $200 million and daily trading volume of $2 million. All dollars in $USD. Chart as of April 9, 2020 market closing prices.

Approximately 2/3rds of the U.S. population live in states with some form of legalized marijuana High growth, local-market focus, and highly fragmented Majority of local dispensaries and growers lack expertise to vertically integrate and create scale Most industry investment has been for geographic expansion and top line growth “Green-fjeld” investments with insuffjcient cash for operations has compressed valuations

1 2 3 4 5

SLIDE 6

62.5% 21% 16%

6 | VEXT SCIENCE

VEXT SCIENCE

Track Record of Growth and Profjtability Continues with Outlook

Delivering Consistent Financial Performance

Net income positive since 2016 Consistent EBITDA margin of 20%+ Executing a growth model that scales

2020 EBT Contributions

Management Agreements Investments & Service Agreements Joint Ventures

1 2 3

$8 $14 $18 $22 $38

$1 $4 $4 $3 $8 $3 $6 $6 $4 $10 $0 $5 $10 $15 $20 $25 $30 $35 $40

2016 A 2017 A 2018 A 2019 A 2020 E

Revenue EBT EBITDA

SLIDE 7

State Cultivation Processing and/

r Wholesale

Retail Products Vapen Brand THC Marijuana CBD Cannabinoids Vext Relationship

Arizona HQ (2) X X X X X Management Agreements Kentucky X X Joint Venture Hawaii X Investment Nevada X X Service Agreement Oklahoma X X X Joint Venture California X X X Joint Venture Ohio X X X Investment Massachusetts X X X Joint Venture

7 | VEXT SCIENCE

9 OPERATIONAL VENTURE PARTNERSHIPS 2020

SLIDE 8

8 | VEXT SCIENCE

ARIZONA ROOTS

Arizona cannabis market is the 3rd largest in the U.S.

$750 million in sales annually
Allowable dispensary capped at 131
Expected to go recreational in 2020

Established Phoenix presence

Herbal Wellness Center – dispensary
Organica – dispensary
Indoor cultivation
Outdoor growing capability
Retail store that can be moved to Phoenix Metro
The Wellness Spot - CBD
Created leading brand identifjed with quality

and purity

Arizona market share leader with distribution

in 80%+ of operating dispensaries

Vertically integrated model with expertise in

extraction and manufacturing

SLIDE 9

9 | VEXT SCIENCE

COMPETITIVE ADVANTAGES

Drive Growth and Margin

GROWTH

Competitive Advantages

MARGIN

Competitive Advantages

Product quality Brand strength Distribution capabilities Manufacturing processes Established supply chain Effjcient marketing spend Working capital GROWTH DRIVERS

Expanding our proven brand for all product lines into new markets

MARGIN DRIVERS

Driving scale with lower costs entering new markets, lower customer acquisition costs, and lower working capital required for operations in new markets

SLIDE 10

10 | VEXT SCIENCE

PRODUCT OVERVIEW

Full line of THC and CBD products

Solicit and implement feedback from customer base Credentialed team with backgrounds in University level research and industry experience Use quality inputs from controlled cultivation of

rganically grown fmower

Maintain consistent purity and quality through stringent operations and quality-controlled manufacturing Diversifjed product line

ffering, new product

introductions and delivery methods

SLIDE 11

11 | VEXT SCIENCE

BRAND STRENGTH

Built on Commitment to Wellness

Second Largest Social Media Following And Exceeds The Next 10 Brands Combined

Core commitment to wellness means consistently

pure, highest quality products

The brand commitment builds alliances with

leading performers who promote Vapen to their fans

Vapen has one of the industry’s largest social

media followings with over 60K on Instagram and 15K on Facebook

Vapen’s brand resonates with consumers across

demographic segments

Brand strength facilitates wholesale distribution

and joint venture partnerships

SLIDE 12

12 | VEXT SCIENCE

WELL DEVELOPED DISTRIBUTION

Broad Arizona market distribution through retail and wholesale channel Arizona recreational use vote in 2020 potentially expands core market Carried in most licensed Arizona dispensaries Ventures in seven new states all processing and selling Vapen branded products.

01 03 02 04

SLIDE 13

13 | VEXT SCIENCE

OPERATIONAL PROCEDURES

In Extraction Processes and Science-based Manufacturing

STRONG

Core expertise of leadership team in manufacturing, distribution and product development Ongoing investment in equipment, processes and human capital to drive effjciency and quality Established manufacturing processes to ensure consistency and quality Scientifjcally credentialled lab staff at PhD levels in

rganic chemistry

Platform for JV partnership growth providing crucial expertise in:

SOPs (Standard Operating Procedures)
Branding
Equipment and cannabinoid extraction techniques
Operational safety and compliance

SLIDE 14

14 | VEXT SCIENCE

FOCUS ON OPERATIONS

Key to future growth

Vext is leveraging cannabis operational expertise into low-risk growth in new markets to add revenue streams and cash fmow through joint venture partnerships targeting operators with:

Deep knowledge of the local market
Manufacturing and cultivation capabilities with access to biomass
Operating stakeholders committed to investing capital and real estate

Full product lines in THC and CBD with established brands Proven supply chain and reliable sourcing Innovative processes and delivery methods focused

n lab and science

Distribution capabilities

SLIDE 15

15 | VEXT SCIENCE

ENTERING NEW MARKETS

Strategically with joint venture partnerships, management agreements, and investments No long-term liabilities from “greenfjeld” spend to build and own new operations

Targeting operations that can rapidly contribute net income and cash flow

Focused on low cost operations
Structured to repay working capital prior to profjt distribution
All cap-ex in equipment, no real estate purchases or leases

Capital requirement for ongoing seven state expansion of approximately USD$5.5 million, with working capital need of ~USD$4.0 million that is fully funded

Lower costs to enter new markets with proven brands and

leveraging existing supply chains

Lower customer acquisitions costs with extensive media library
f assets and one of the industry’s highest social media following
Signifjcant ROI and payback

Creates pipeline of future acquisitions and partnerships

SLIDE 16

16 | VEXT SCIENCE

GROWING FOOTPRINT

Operational in Seven States

Legal Legal for medical use Voting in 2020 Vext HQ Vext JV Location Targeting 9 total joint venture, management service agreements, and investments closed and operational by the end of CY2020 Tracking to add 2 – 3 new markets in 2020 to come online in 2021

SLIDE 17

17 | VEXT SCIENCE

JV PARTNERSHIP ROLL OUT

MAR APR MAY SEPT OCT FEB APR MAY JUN OCT 2019 2020

San Diego Build Out San Diego LOI Arkansas LOI Oklahoma LOI Ohio LOI Mass. LOI Hawaii LOI Las Vegas Building Begins Hawaii Lab Build Out Oklahoma Production Begins San Diego Production Begins Kentucky LOI OK, AK, KY Building Begins Kentucky Production Began Ohio Processing Begins Las Vegas Production Begins

Mass. Production

Begins

SLIDE 18

18 | VEXT SCIENCE

PRODUCT MIX

With new distribution

Current Sales Breakdown by Product*

Increasing Vapen branded products as a percentage of revenue.

Future Sales Breakdown by Product**

SLIDE 19

19 | VEXT SCIENCE

REDUCING INVESTMENT

Reinvesting Cash to Fund Growth

USES OF CASH SOURCES OF CASH APPLYING ROI

START-UP PHASE

Investment partnership signed and

announced

Build-out facility and purchase equipment

WORKING CAPITAL COSTS

$250,000+ for each stakeholder
Cover initial biomass, packaging, labor,

permitting

Working capital returned prior to profjt

distribution OPERATIONAL PHASE

Revenue comes on stream; Consolidated

revenue and net income booked on Vext Science P&L

Debt repaid and venture turns cash fmow

positive

Cash begins to build on Vext Science

balance sheet FUTURE USE OF CAPITAL

Limit or reduce exposure in weaker markets
Increase investment in attractive markets

BENEFITS OF VEXT MODEL

Observe the impact of the characteristic
f each market and state’s regulation on
perations before making further invest-

ments

Identify most attractive markets and
pportunities for further investment

Risk to maximize return

SLIDE 20

Revenue and EBITDA Forecast (USD$)

17% EBITDA margin 26% EBITDA margin

$22.0 $38.0 $3.7 $10.0 2019 2020E

+73% +170% 20 | VEXT SCIENCE

ATTRACTIVE GROWTH FORECAST

Vext Target Metrics:

2020 Growth Drivers:

Organic, low teens growth from Arizona business in 2020 with estimated mid-twenty percent growth through expanded recreational use in 2021 Leverage organic growth with JV partnerships and acquisitions Long-term EBITDA margin in a range

f 20%+
Primarily from new management agreements coming online
EBITDA grows as a % of revenue on expansion

SLIDE 21

21 | VEXT SCIENCE

KEY TAKE-AWAYS

TRACK RECORD

Proven operational capabilities in cannabis industry

ACCELERATING TOPLINE GROWTH AND EARNINGS MARGIN

Ventures coming online and contributing in 2020 to revenue and higher EBITDA

MULTI-YEAR STRATEGY

Expand to 11+ states and internationally operations by 2022

SLIDE 22

VEXT SCIENCE

PROFITABLE PRODUCER OF MEDICAL AND CONSUMER CANNABIS APPENDIX Supplemental Financial Information www.vextscience.com

SLIDE 23

December 31, 2019 December 31, 2018 REVENUES Management fees $ 4,638,000 $4,800,000 Professional services 6,458,297 6,652,534 Product sales 9,949,209 5,342,956 Equipment leasing 1,019,403 1,000,779 Property leasing 257,659 680,000 22,322,568 18,476,269 COST OF SALES Cost of goods sold 6,607,533 3,726,520 Salaries and wages and contractors 5,545,340 4,890,750 Property and equipment leasing, utilities, and property taxes 103,948 204,045 Amortization 697,899 480,603 (12,954,720) (9,301,918) Gross Profit 9,367,848 9,174,351 Gross Margin 42% 50% Operational expenses (5,699,619) (4,294,357) Net income after taxes 2,793,324 3,748,562 EBITDA 3,737,623 4,981,182 23 | VEXT SCIENCE

FINANCIAL SUMMARY

December 31, 2019 December 31, 2018 All fjgures above are audited except for EBITDA

SLIDE 24

24 | VEXT SCIENCE

CAP TABLE

ISSUED AND OUTSTANDING

Commons shares o/s 22,616,226 24.8% Class A super voting shares post conversation (owned by the Executive Chairman) 60,574,700 66.5% Class A super voting shares post conversation 7,872,400 8.6% Total issued and o/s voting shares 91,063,326 100%

OTHER SECURITIES

Special advisory warrants & other warrants 1,980,210 Stock options 2,066,334 Fully diluted 95,109,870

*Each Class A super voting share is convertible into 100 common shares

SLIDE 25

25 | VEXT SCIENCE

MANAGEMENT TEAM

THAI NGUYEN | EXECUTIVE CHAIRMAN/FOUNDER

Mr. Nguyen is the Executive Chairman and Founder of Vext Science and the Vapen

Brands (Vapen Clear, Vapen Extracts, Vapen Kitchens, & Vapen CBD). Mr. Nguyen formed Vext Science to service Herbal Wellness Center. In 2013, he developed the Vapen Brand to be sold retail and wholesale to the other Arizona dispensaries. Mr. Nguyen has been involved with entrepreneurial ventures in real estate and High Performance Automotive over the past 18 years. He is a visionary leader in the cannabis industry focusing on trends, relationships and a strong culture

ERIC OFFENBERGER | CHIEF EXECUTIVE OFFICER/COO

Mr. Offenberger has 30+ year leading organizations in the distribution and

manufacturing industries. Eric has worked in both large public companies and private organizations that have been market leaders. As President and COO of a Steel Service Center he oversaw six divisions with annual revenue of over$350 million. Mr. Offenberger has a proven track record growing sales, improving inventory turnover and driving operational effjciencies. He has been involved in green fjeld startups as well as major capital development and installation of ERP applications. Mr. Offenberger holds a bachelors degree in accountancy and CPA certifjcation.

DENISE LOK | CHIEF FINANCIAL OFFICER BRIAN CAMERON| CORPORATE SECRETARY

Ms. Lok is a Chartered Professional Accountant and holds a Bachelor of

Commerce degree in Accounting and Transportation Logistics from the University of British Columbia. Ms. Lok brings a broad background of public company experience. Previously, she was an auditor with PricewaterhouseCoopers.

Mr. Cameron is the managing partner of Cameron & Associates, a corporate

fjnance consultancy with offjces in Canada and the United States, providing

ngoing corporate fjnance consulting. Mr. Cameron was previously employed by

the British Columbia Securities Commission and the Vancouver Stock Exchange.

SLIDE 26

26 | VEXT SCIENCE

MANAGEMENT TEAM

DR. STEPHEN DAVIDOWSKI

DIRECTOR OF RESEARCH & DEVELOPMENT

MICHAEL SETH

DIRECTOR OF EXTRACTION AND LABS

ANTHONY “TONY” GUTIERREZ

DIRECTOR OF CULTIVATION AND AGRICULTURE Stephen holds a Ph.D. in Chemistry with vast experience in the research and development of several classes of inorganic and organic materials. He has strong problem-solving skills, applying theoretical and experimental technical knowledge to elucidate mo- lecular structures and interactions in complex chem- ical systems. Stephen is an excellent team worker, having developed several long-lasting collaborations across multiple interdisciplinary teams exemplifjed by extensive publications about a wide array of technolo-

gies. He has exceptional communication and presen-

tation skills developed by extensive participation in scientifjc conferences as well as teaching experience at ASU. Mike has been involved with Vapen Extraction and Labs from day one. He was instrumental with devel-

ping the operating process and protocols ensuring

quality and consistency within the product lines. Mike graduated from Arizona State University, with a bachelor’s degree in biochemistry. Mike is currently working on a doctorate degree in Chemistry at Arizo- na State University. Tony has assisted Vext in our growth of cultivation capabilities and evaluating cultivation opportunities in new states and with new partnerships. In addition to his education and experience in cannabis, Tony has an extensive construction background that has allowed Vapen to increase our canopy space effjciently. Tony holds a bachelor’s degree in Plant Science from Arizona State University and is currently in the docto- rial program at Arizona State University.

SLIDE 27

27 | VEXT SCIENCE

MANAGEMENT TEAM

THOMAS SCOTT PIERCE | DIRECTOR OF RETAIL OPERATIONS

Scott Pierce is a Washington, D.C. Native who began his work in the cannabis industry in the late 1980’s, where he volunteered for NORML and attended many events supporting cannabis legalization. He was taught the many benefjts of this amazing plant, by some of the Pioneers of the Cannabis Industry...Jack Herer, Steve DeAngelo and Ed Rosenthal. Scott has an extensive background in Sales, Manage- ment, Hospitality, the Food/Beverage Industry and Customer Service. He is also an accomplished actor/entertainer/event planner that ran an award winning, non-profjt theater/art gallery for 8 years in Downtown Phoenix called Artists Theater Project. Scott applied his many skills to build one of the most successful Medical Marijuana Dispensaries in Phoenix, AZ.

BRIAN OFFENBERGER | DIRECTOR OF SALES AND MARKETING

Brian Offenberger is responsible for sales and marketing for all Vext Science ventures. Brian has a proven executive management track record and experience driving sales growth in a variety of industries. Prior to joining Vext Science, Brian was Chief Executive Offjcer of Right On – No Bull Marketing with responsibility for all aspects

f the business. He also hosted a podcast about online marketing best practices that

marketing pros ranked #3 in the world for online marketing information. Previously, he served as Western Regional Director for Siemens, leading the division to record sales and profjts. Brian holds professional certifjcations in online marketing, search marketing, website analytics, paid search advertising, conversion optimization and email marketing.

DAVID ROZEN | DIRECTOR OF STRATEGIC DEVELOPMENT COREY BARNES | CULINARY DIRECTOR

David brings an entrepreneurial background to Vext Science. David is responsible for identifying new market and partnership opportunities. Prior to joining Vext full time, David had successfully obtained cannabis licenses in two states. David’s hands on experience with the licensing and construction aspects for new operations, has helped Vext and our partners avoid numerous pitfalls in executing our growth strategy. Corey has been involved in the start up and development of products using cannabis for 7+ years. Corey has been involved in starting brands prior to joining

Vext. Corey’s background in the culinary industry has allowed Corey to grow the

product offering of Vapen and earning multiple industry award recognition for product quality.

SLIDE 28

28 | VEXT SCIENCE

BOARD OF DIRECTORS

THAI NGUYEN | EXECUTIVE CHAIRMAN ERIC OFFENBERGER | CEO

BOARD OF ADVISORS

MR. DAVID EATON
MS. CAROLINE WILLIAMS
Mr. Eaton has 35+ years capital markets experience. Consulting to both public

and private companies in the areas of investor relations, arranging fjnancings and corporate transactions. Since 2007 he has been Chairman at Baron Global Finan- cial Canada Ltd., a subsidiary of the Hong Kong Stock Exchange Member Firm VBG Group. The fjrm provides merchant banking services in the areas of fjnancing, transaction planning, corporate transactions, public listings and ongoing public company management.

Ms. Williams is based in Toronto, Ontario and has extensive experience in retail
perations. Ms. Williams has been involved in several charity organizations and

currently serves as a board member for MLB UMPSCARE. Ms. Williams background in managing, growing and improving retail operations will be benefjcial to VEXT as the Company expands its distribution and dispensary business in new markets.

DR. JONATHAN SHELTON
DR. JEFF YARGER

SCOTT HILL ESQ.

Dr. Jonathan Shelton is the founder of Brain Fit, LLC a private practice specializing in

psychological assessment and evaluation. Bachelors degree in Psychology at How- ard University in Washington, DC and a Masters and Doctoral degree in Clinical Psy- chology, Arizona School of Professional Psychology. Independently licensed in the state of Arizona for 5+ years. Focusing on Compensation and Pension Examinations for veterans, Consultative Examinations for the AZ Department of Disability Deter- mination, and psychological evaluations for the AZ Department of Child Safety.

Dr. Yarger brings extensive expertise in chemical and pharmaceutical research and

development (R&D) to the Vext advisory board as a leading pharmaceutical R&D in both academic and industrial laboratories for over 20 years, and a professor of chemistry, biochemistry and physics at Arizona State University (ASU). Along with Dr. Yarger’s extensive R&D and publications in pharmaceuticals, he also has signifjcant active research projects in the areas of biophysical chemistry, nanomaterials and biopolymers, with

ver 150 publications in top scientifjc journals.
Mr. Hill brings over two decades of experience in fjnance, business and law and is a

partner with Sirvent and Hill. He continued his education in Physics and Law at ASU, culminating in a juris doctorate in 1999. Scott values helping others protect their investments and assets, as evidenced by his law practice’s focus on patent law and estate

planning. His dedication to superior client communication and outstanding work prod-

uct prompted him to join WealthCounsel, a collaborative network of more than 1,000 law fjrms nationwide, in 2006.

SLIDE 29

VEXT SCIENCE

THANK YOU

e: investors@vextscience.com www.vextscience.com